Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease
- PMID: 22468051
- PMCID: PMC3107419
- DOI: 10.1007/s12291-011-0121-7
Role of cytokines in the pathogenesis of non-alcoholic Fatty liver disease
Abstract
A number of factors are linked with non-alcoholic fatty liver diseases (NAFLD), a condition that ranges from clinically benign fatty liver to its more severe form, non alcoholic steatohepatitis (NASH). In this study, we evaluated the role of cytokines secreted from adipose tissue in the pathogenesis and progression of NAFLD. We also compared anthropometric profile, lipid profile and insulin resistance data in 105 NAFLD patients with 77 normal subjects. These subjects showed a normal serum albumin level, prothrombin time and renal function but elevated aminotransferases. Predisposing factors were diabetes mellitus (35%), overweight (56%) and hyperlipidemia (44%). Insulin resistance (IR), determined by homeostasis model assessment (HOMA) was confirmed in 70% patients with NAFLD and 42% patients fulfilled the minimum criteria for insulin resistance syndrome (IRS). NAFLD patients showed elevated levels of pro-inflammatory cytokines tumor necrosis factor (TNF)-α, and interleukin (IL)-6, while anti-inflammatory cytokines IL-4 level decreased and IL-10 level remain unchanged; however, TGF-β1 level elevated significantly compared to normal subjects. While insulin level and HOMA-IR both were significantly positively correlated with BMI, waist-to-hip ratio, total cholesterol, VLDL-cholesterol, triglyceride and TGF-β1; glucose, IL-6 and TNF-α levels were significantly positively correlated with HOMA-IR only. In conclusion, pro-inflammatory cytokines play an important link between metabolic and liver disorders in the fat accumulation, and thereby cause IR, inflammation and liver fibrosis.
Electronic supplementary material: The online version of this article (doi:10.1007/s12291-011-0121-7) contains supplementary material, which is available to authorized users.
Keywords: Insulin resistance; Interleukin-6; Non-alcoholic fatty liver disease; Transforming growth factor beta; Tumor necrosis factor-alpha.
Figures
Similar articles
-
The Relationship between Insulin Resistance and Liver Damage in non-alcoholic Fatty Liver Patients.Sisli Etfal Hastan Tip Bul. 2020 Dec 11;54(4):411-415. doi: 10.14744/SEMB.2018.83604. eCollection 2020. Sisli Etfal Hastan Tip Bul. 2020. PMID: 33364879 Free PMC article.
-
The clinical significance of insulin resistance in non-diabetic patients with early forms of non-alcoholic fatty liver disease.Ter Arkh. 2018 Aug 27;90(8):63-68. doi: 10.26442/terarkh201890863-68. Ter Arkh. 2018. PMID: 30701940
-
Role of APN and TNF-α in type 2 diabetes mellitus complicated by nonalcoholic fatty liver disease.Genet Mol Res. 2015 Apr 10;14(2):2940-6. doi: 10.4238/2015.April.10.1. Genet Mol Res. 2015. PMID: 25966055
-
Non-alcoholic Fatty Liver Disease and Metabolic Syndrome-Position Paper of the Indian National Association for the Study of the Liver, Endocrine Society of India, Indian College of Cardiology and Indian Society of Gastroenterology.J Clin Exp Hepatol. 2015 Mar;5(1):51-68. doi: 10.1016/j.jceh.2015.02.006. Epub 2015 Mar 6. J Clin Exp Hepatol. 2015. PMID: 25941433 Free PMC article. Review.
-
The role of cytokines in non-alcoholic fatty liver disease.Dig Dis. 2010;28(1):179-85. doi: 10.1159/000282083. Epub 2010 May 7. Dig Dis. 2010. PMID: 20460908 Review.
Cited by
-
Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases).Rev Endocr Metab Disord. 2024 May 6. doi: 10.1007/s11154-024-09884-y. Online ahead of print. Rev Endocr Metab Disord. 2024. PMID: 38709387 Review.
-
Unlocking the Therapeutic Potential of Ellagic Acid for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis.Antioxidants (Basel). 2024 Apr 18;13(4):485. doi: 10.3390/antiox13040485. Antioxidants (Basel). 2024. PMID: 38671932 Free PMC article. Review.
-
Interleukins: Pathogenesis in Non-Alcoholic Fatty Liver Disease.Metabolites. 2024 Mar 6;14(3):153. doi: 10.3390/metabo14030153. Metabolites. 2024. PMID: 38535313 Free PMC article. Review.
-
Effects of Sophora alopecuroides in a High-Concentrate Diet on the Liver Immunity and Antioxidant Function of Lambs According to Transcriptome Analysis.Animals (Basel). 2024 Jan 5;14(2):182. doi: 10.3390/ani14020182. Animals (Basel). 2024. PMID: 38254353 Free PMC article.
-
Advances in Noninvasive Biomarkers for Nonalcoholic Fatty Liver Disease.Metabolites. 2023 Oct 29;13(11):1115. doi: 10.3390/metabo13111115. Metabolites. 2023. PMID: 37999211 Free PMC article. Review.
References
-
- Ludwig J, Viggiano TR, McGill DB, Ott BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55:434–438. - PubMed
-
- Das SK, Mukherjee S, Vasudevan DM. Non-alcoholic fatty liver diseases: an under recognized cause with emerging importance. Current Sci. 2006;90:659–665.
LinkOut - more resources
Full Text Sources